CSL Limited (CSLLY) Price and Market Data

CSL Limited is an Australian biotechnology company specializing in plasma-derived therapies, vaccines and specialty medicines. Its CSL Behring division develops and supplies immunoglobulins, albumin, coagulation products and therapies for rare and serious diseases, while CSL Seqirus focuses on influenza vaccines and pandemic preparedness. The company operates plasma collection, manufacturing and research infrastructure across multiple regions. CSL’s results depend on plasma supply, manufacturing yields, regulatory approvals, healthcare reimbursement, vaccine demand and the success of its specialty medicine pipeline.